MELBOURNE, Australia, and Princeton, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel ...
Probe has completed the second year of its three-year environmental baseline studies and is on schedule to complete these studies in 2025. The environmental baseline studies are key to securing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback